{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:14:05Z","timestamp":1789146845596,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109585","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:14:55Z","timestamp":1787181295000},"page":"109585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France"],"prefix":"10.1016","volume":"220","author":[{"given":"Nicolas","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Macouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Debieuvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Audigier-Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"L\u00e9na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radj","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Remon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Justeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chouaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"P\u00e9rol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2026.109585_b0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109585_b0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109585_b0015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-Line Immunotherapy for Non-Small-Cell Lung Cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.lungcan.2026.109585_b0020","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2012.42.2352","article-title":"Randomized controlled trials and comparative effectiveness research","volume":"30","author":"Hahn","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109585_b0025","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses","volume":"175","author":"Prasad","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lungcan.2026.109585_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2015.10.014","article-title":"Standards and guidelines for observational studies: quality is in the eye of the beholder","volume":"71","author":"Morton","year":"2016","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109585_b0035","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"16","key":"10.1016\/j.lungcan.2026.109585_b0040","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2017.72.6414","article-title":"Untapped potential of Observational Research to Inform Clinical Decision making: American Society of Clinical Oncology Research Statement","volume":"35","author":"Visvanathan","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109585_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023568","article-title":"The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)","volume":"9","author":"P\u00e9rol","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109585_b0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11523-021-00848-9","article-title":"A real-world study of patients with advanced non-squamous non-small cell lung cancer with EGFR exon 20 insertion: clinical characteristics and outcomes","volume":"16","author":"Chouaid","year":"2021","journal-title":"Target. Oncol."},{"key":"10.1016\/j.lungcan.2026.109585_b0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.lungcan.2021.10.017","article-title":"Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort","volume":"62","author":"Girard","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109585_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2022.08.001","article-title":"Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany","volume":"172","author":"Griesinger","year":"2022","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109585_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/cancers14010092","article-title":"Biomarker testing in older patients treated for an Advanced or Metastatic Non-squamous Non-Small-Cell Lung Cancer: the French ESME real-life multicenter cohort experience","volume":"14","author":"Lamy","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109585_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103473","article-title":"Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort","volume":"9","author":"Thomas","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2026.109585_b0075","doi-asserted-by":"crossref","unstructured":"Cabart M, Mourey L, Pasquier D, Schneider S, L\u00e9na H, Girard N, et al. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database. J Geriatr Oncol. 202415(7):101819.","DOI":"10.1016\/j.jgo.2024.101819"},{"issue":"21","key":"10.1016\/j.lungcan.2026.109585_b0080","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/cancers16213563","article-title":"Optimizing Treatment strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights","volume":"16","author":"Thomas","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2026.109585_b0085","article-title":"Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy","volume":"84","author":"Valette","year":"2023","journal-title":"Respir Med Res."},{"key":"10.1016\/j.lungcan.2026.109585_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108499","article-title":"Clinical characteristics and management of long survivors in extensive stage small cell lung cancer","volume":"202","author":"Gobbini","year":"2025","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109585_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2022.101423","article-title":"Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort","volume":"14","author":"Bringuier","year":"2023","journal-title":"J Geriatr Oncol."},{"issue":"24","key":"10.1016\/j.lungcan.2026.109585_b0100","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.3390\/cancers14246148","article-title":"Effectiveness of Nivolumab in Second-Line and later in patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts","volume":"14","author":"Chouaid","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2026.109585_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107280","article-title":"Reduced risk of secondary primary extra pulmonary cancer in advanced\/metastatic lung cancer patients treated with immune checkpoint inhibitors","volume":"182","author":"Heudel","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109585_b0110","unstructured":"Belaroussi Y, Bouteiller F, Bellera C, Pasquier D, Perol M, Debieuvre D, Filleron T, Girard N, Schott R, Mathoulin-P\u00e9lissier S, Martin AL, Cousin S. Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting. Sci Rep. 2023413(1):9584."},{"key":"10.1016\/j.lungcan.2026.109585_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108548","article-title":"Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study","volume":"203","author":"Chouaid","year":"2025","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109585_b0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12874-025-02500-w","article-title":"Addressing challenges with Matching-Adjusted indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer","volume":"25","author":"Esnault","year":"2025","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.lungcan.2026.109585_b0125","doi-asserted-by":"crossref","unstructured":"Justeau G, Chouaid C, Debieuvre D, Audigier-Valette C, Quantin X, L\u00e9na H, et al Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis. Front Oncol. 2025;15:1526931.","DOI":"10.3389\/fonc.2025.1526931"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109585_b0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12325-022-02408-7","article-title":"An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth factor Receptor Exon 20 Insertion Mutations","volume":"40","author":"Chouaid","year":"2023","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109585_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/JTO.0b013e3181c41e8d","article-title":"Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis","volume":"5","author":"Subramanian","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109585_b0140","doi-asserted-by":"crossref","unstructured":"Couraud S, Ferretti G, Milleron B, Cortot A, Girard N, Gounant V, et al. Intergroupe francophone de canc\u00e9rologie thoracique, Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise, and Soci\u00e9t\u00e9 d'imagerie thoracique statement paper on lung cancer screening. Diagn Interv Imaging. 2021;102(4):199-211.","DOI":"10.1016\/j.diii.2021.01.012"},{"key":"10.1016\/j.lungcan.2026.109585_b0145","unstructured":"https:\/\/www.ispor.org\/docs\/default-source\/cti-meeting-21305-documents\/fb9e8304-33a1-4f76-b49b-96cd7fbed3a2.pdf?sfvrsn=d5f34ddd_0."},{"key":"10.1016\/j.lungcan.2026.109585_b0150","doi-asserted-by":"crossref","unstructured":"Debieuvre D, Falchero L, Molinier O, Couraud S, Cortot A, Meyer N, et al. Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020. NEJM Evid. 2025;4(7):EVIDoa2400443.","DOI":"10.1056\/EVIDoa2400443"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109585_b0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.lungcan.2009.01.020","article-title":"Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?","volume":"66","author":"Hsu","year":"2009","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022600646X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022600646X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:53:45Z","timestamp":1789145625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022600646X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S016950022600646X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109585","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109585"}}